Allergan Aesthetics Reveals Evolution in Approach to Modern Aesthetic Treatments

Global data from over 12,000 consumers signals the future of modern aesthetics will be multimodal treatment plans and holistic, natural results

Mar. 19, 2026 at 7:25am

Got story updates? Submit your updates here. ›

Allergan Aesthetics, an AbbVie company and global leader in medical aesthetics, announced new global consumer research highlighting how patient expectations in medical aesthetics are evolving, and will present the next evolution of its AA Signature™ framework to address this changing treatment need, at the AMWC 2026 in Monaco.

Why it matters

The findings are based on one of the largest global consumer studies exploring attitudes toward aesthetic treatments, surveying more than 12,000 beauty-involved consumers across nine countries. The research provides new insight into how patients are navigating an expanding range of aesthetic options and the growing role practitioners play in guiding treatment decisions.

The details

The research found that 62% of consumers find multiple aesthetic treatments appealing, 59% are likely to adopt a structured multi-treatment approach, and 78% would feel more satisfied with their aesthetic journey working to an agreed long-term plan with their practitioner. Allergan Aesthetics is evolving its AA Signature™ framework to include new elevated looks, expanded indications and enhanced product integration, reflecting changing patient expectations.

  • Allergan Aesthetics will launch the research findings in a new report Layered Beauty: The New Aesthetic Mindset at AMWC 2026.
  • AA Signature™ Skin 360+ will be presented at AMWC 2026, designed around the way the skin behaves across layers and dimensions.

The players

Mark Wilson

Senior Vice President, International, Allergan Aesthetics.

Allergan Aesthetics

An AbbVie company and global leader in medical aesthetics.

Got photos? Submit your photos here. ›

What they’re saying

“Medical aesthetics is entering an exciting era, where patients are embracing a broader, more holistic perspective on their treatment journeys.”

— Mark Wilson, Senior Vice President, International, Allergan Aesthetics

“At AMWC, our program provides a tangible demonstration of how Allergan Aesthetics has built a portfolio and education platform to help healthcare professionals deliver the results their patients' want. We continue to learn and evolve our proprietary multimodal approach, AA Signature™ through the introduction of elevated Signature Looks”

— Mark Wilson, Senior Vice President, International, Allergan Aesthetics

What’s next

Allergan Aesthetics will bring the research insights and AA Signature™ evolution to life through two flagship symposia delivered by the Allergan Medical Institute (AMI) at AMWC 2026.

The takeaway

Allergan Aesthetics' new research and evolution of its AA Signature™ framework demonstrate the industry's shift towards a more holistic, multimodal approach to aesthetic treatments, driven by changing patient expectations for personalized, natural-looking results over time.